BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9

• Press Releases

  Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)

  September 4, 2025

   · 

  6 min read
• Press Releases

  Pluristyx and BioLamina Announce Strategic Partnership to Accelerate Development of Stem Cell-Based Therapies

  September 4, 2025

   · 

  4 min read
• Press Releases

  NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference

  September 4, 2025

   · 

  2 min read
• Press Releases

  Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10

  September 4, 2025

   · 

  4 min read
• Press Releases

  Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

  September 4, 2025

   · 

  7 min read
• Press Releases

  GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

  September 4, 2025

   · 

  3 min read
• Press Releases

  Sol-Gel Announces Health Canada Approval of EPSOLAY®

  September 4, 2025

   · 

  8 min read
• Press Releases

  Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States

  September 4, 2025

   · 

  3 min read
• Press Releases

  BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

  September 4, 2025

   · 

  5 min read
• Press Releases

  BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM)

  September 4, 2025

   · 

  5 min read